Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis

Implementation of ATT deprescribing is enabled or constrained by (a) the meaning of medications to patients; (b) clinician engagement and understanding; (c) multi-disciplinary clinical decision-making processes (including support tools); (d) patient empowerment; (e) organizational investment. Addressing these multi-level factors, including the development of SDM tools, can address the prescribing inertia that may cause devastating impacts on patients and their families as well as moral distress amongst healthcare staff. This study was performed as part of the Horizon-Europe funded SERENITY project.

Authors

Institutions

Publication Details

Journal
PLoS Medicine
Published
2025-08-25
DOI
https://doi.org/10.1371/journal.pmed.1004663
Citations
3
Primary Topic
Patient-Provider Communication in Healthcare
Type
article
Field-Weighted Citation Impact
8.45

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis

Justin Jagosh, Fliss EM Murtagh, Mark Pearson, Eric C. T. Geijteman et al.
3 citations
PLoS Medicine
Patient-Provider Communication in Healthcare
8.45
article

Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis

Justin Jagosh, Fliss EM Murtagh, Mark Pearson, Eric C. T. Geijteman, Anette Arbjerg Højen, Adrian Edwards, Adrian Edwards, Frederikus Albertus Klok, Anthony Maraveyas, Kathy Seddon, Simon Noble, Miriam J. Johnson, Gamze Keser, Sarah Greenley, Simon P. Mooijaart
article en
3 citations

Abstract

Implementation of ATT deprescribing is enabled or constrained by (a) the meaning of medications to patients; (b) clinician engagement and understanding; (c) multi-disciplinary clinical decision-making processes (including support tools); (d) patient empowerment; (e) organizational investment. Addressing these multi-level factors, including the development of SDM tools, can address the prescribing inertia that may cause devastating impacts on patients and their families as well as moral distress amongst healthcare staff. This study was performed as part of the Horizon-Europe funded SERENITY project.

PLoS MedicineVol. 22(8)
University of Hull (GB), Aalborg University Hospital (DK), Leiden University Medical Center (NL), Erasmus MC Cancer Institute (NL), Hull York Medical School (GB), Cardiff University (GB), Aalborg University (DK)
UK Research and Innovation, National Institute for Health and Care Research, Department of Health and Social Care, European Commission, Cardiff University, HORIZON EUROPE Framework Programme
Openalex Percentile: Top 2%
Patient-Provider Communication in Healthcare
8.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.